Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Carvykti (ciltacabtagene autoleucel)
i
Other names:
JNJ-4528, JNJ 4528, cilta-cel, JNJ4528, JNJ68284528, LCARB38M, LCAR B38M, LCAR-B38M, anti-BCMA CAR-T, LCAR-B38M CAR-T, JNJ-68284528, JNJ 68284528
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
J&J, Legend Biotech
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs:
‹
idecabtagene vicleucel (2)
CB-011 (2)
ACLX-001 (1)
ALLO-605 (1)
ALLO-715 (1)
AZD0120 (1)
equecabtagene autoleucel (1)
PBCAR269A (1)
bb21217 (1)
AUTO2 (0)
Autologous CAR-T cells (0)
BCMA CAR-T cell therapy (0)
BCMA targeted CAR T (0)
BCMA targeted CAR T-cells (0)
BCMA-BCL2L1-CART (0)
BCMA-PD1-CART Cells (0)
BMS-986354 (0)
CART-138/BCMA/19/more (0)
CART-BCMA/CS1 (0)
CD19/BCMA targeted CAR T-cells (0)
CTX120 (0)
CYAD-211 (0)
Descartes-08 (0)
FCARH143 (0)
FHVH-BCMA-T (0)
IBI346 (0)
KITE-585 (0)
MCARH125 (0)
MCM998 (0)
MDC-CAR-BCMA001 (0)
MTV273 (0)
OriC321 (0)
P-BCMA-101 (0)
RG6538 (0)
CART-ddBCMA (0)
anti-BCMA CAR-T cells (0)
ARI0002h (0)
PHE885 (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
JCARH125 (0)
senl_BCMA (0)
CT053 (0)
idecabtagene vicleucel (2)
CB-011 (2)
ACLX-001 (1)
ALLO-605 (1)
ALLO-715 (1)
AZD0120 (1)
equecabtagene autoleucel (1)
PBCAR269A (1)
bb21217 (1)
AUTO2 (0)
Autologous CAR-T cells (0)
BCMA CAR-T cell therapy (0)
BCMA targeted CAR T (0)
BCMA targeted CAR T-cells (0)
BCMA-BCL2L1-CART (0)
BCMA-PD1-CART Cells (0)
BMS-986354 (0)
CART-138/BCMA/19/more (0)
CART-BCMA/CS1 (0)
CD19/BCMA targeted CAR T-cells (0)
CTX120 (0)
CYAD-211 (0)
Descartes-08 (0)
FCARH143 (0)
FHVH-BCMA-T (0)
IBI346 (0)
KITE-585 (0)
MCARH125 (0)
MCM998 (0)
MDC-CAR-BCMA001 (0)
MTV273 (0)
OriC321 (0)
P-BCMA-101 (0)
RG6538 (0)
CART-ddBCMA (0)
anti-BCMA CAR-T cells (0)
ARI0002h (0)
PHE885 (0)
multi-target gene-modified CAR-T/TCR-T cell immunotherapy (0)
JCARH125 (0)
senl_BCMA (0)
CT053 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
ciltacabtagene autoleucel
Sensitive: A1 - Approval
ciltacabtagene autoleucel
Sensitive
:
A1
ciltacabtagene autoleucel
Sensitive: A1 - Approval
ciltacabtagene autoleucel
Sensitive
:
A1
TNFRSF17 overexpression
Multiple Myeloma
TNFRSF17 overexpression
Multiple Myeloma
ciltacabtagene autoleucel
Sensitive: C3 – Early Trials
ciltacabtagene autoleucel
Sensitive
:
C3
ciltacabtagene autoleucel
Sensitive: C3 – Early Trials
ciltacabtagene autoleucel
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login